EURETINA 2020: Preliminary Real-World Results Suggest Switch From Aflibercept to Ranibizumab Due to Lack of Efficacy in Diabetic Macular Edema May Prove Beneficial
The ongoing PRECISE study will reveal the anatomical outcomes of eyes that are switched
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.